Antiviral actions of flavanoid-derived compounds on dengue virus type-2

International Journal of Biological Sciences

Volumn 6, Issue 3, 2010, Pages 294-302

  Muhamad, Mudiana ^a   Kee, Lee Yean ^a   Abd Rahman, Noorsaadah ^a   Yusof, Rohana ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Cytophatic effects; Dengue virus type 2; Flavanoid; In vitro inhibition; Inhibitory activity; Plaque assay

Indexed keywords

DENGUE VIRUS GROUP; DENGUE VIRUS TYPE 2; FLAVIVIRIDAE;

EID: 77953308454     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.6.294     Document Type: Article

References (14)

1. [Internet] WHO. Dengue Guidelines for Diagnosis, Treatment, Prevention and Control; New Edition 2009; A joint publication of the World Health Organization (WHO) and the Special Programme for Research and Training in Tropical Diseases (TDR). http://whqlibdoc.who.int/publications/2009/9789241547871_eng.pdf
2. Halstead SB, Heinz FX, Barrett ADT and Roehrig JT. Dengue virus: molecular basis of cell entry and pathogenesis, 25-27 June 2003, Vienna, Austria. Vaccine. 2005; 23: 849-856.
3. Malavige GN, Fernando S, Fernando DJ and Seneviratne SL. Dengue viral infections. Postgrad Med J. 2004; 80: 588-601.
4. Henchal EA and Putnak JR. The dengue viruses. Clin Microbiol Rev. 1990; 3(4): 376-396.
5. Halstead SB and Deen J. The future of dengue vaccines. Lancet. 2002; 360: 1243-1245.
6. Sampath A and Padmanabhan R. Molecular targets for flavivirus drug discovery. Antiviral Research. 2009; 81: 6-15.
7. Lee YK. Synthesis for potential inhibitor as therapeutics agent against dengue virus protease (PhD Thesis). University of Malaya. 2010.
8. Morens DM, Halstead SB, Repik PM, Putvatana R and Raybourne N. Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization. J Clin Microbiol. 1985; 22: 250-254.
9. Tan SK, Pippen R, Yusof R, Ibrahim H, Khalid N and Rahman NA. Inhibitory activity of cyclohexenyl chalcone derivatives and flavonoids of fingerroot, Boesenbergia rotunda (L.), towards dengue-2 virus NS3 protease. Bioorg Med Chem Lett. 2006; 16: 3337-3340.
10. Phoolcharoen W and Smith DR. Internalization of the dengue virus is cell cycle modulated in HepG2, but not Vero cells. J Med Virol. 2004; 74(3): 434-441.
11. Marianneau P, Steffan AM, Royer C, Drouet MT, Kirn A and Deubel V. Differing infection patterns of dengue and yellow fever viruses in a human hepatoma cell line. J Infect Dis. 1998; 178: 1270-1278.
12. Premanathan M, Kathiresan K, Yamamoto N and Nakashima H. In vitro anti-human immunodeficiency virus activity of polysaccharide from Rhizopora mucronata Poir. Biosci Biotechnol Biochem. 1999; 63(7): 1187-1191.
13. Parida MM, Upadhyay C, Pandya G and Jana AM. Inhibitory potential of neem (Azadirachta indica Juss) leaves on dengue virus type-2 replication. J Ethnopharm. 2002; 79: 273-278.
14. Wentworth BB and French L. Plaque assay of cytomegalovirus strains of human origin. Proc Soc Exp Biol Med. 1970; 135(2): 253-258.